Acronis Visionary Approach to Cybersecurity for MSPs Highlighted in Frost Radar™: Endpoint Security, 2023 11-12-2023, 20:01

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound 9-07-2024, 07:00

GA-ASI Performs Cold Weather Validation Using MQ-9B SkyGuardian 25-02-2023, 01:00